Ascendis Pharma A/S (BVMF:A1SN34)

Ascendis Pharma Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 3, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	64,965	50,925	34,572	36,074	42,542	46,776
Market Cap Growth	54.98%	47.30%	-4.17%	-15.20%	-9.05%	75.22%
Enterprise Value	66,674	52,050	35,652	34,094	37,197	41,140
Last Close Price	70.21	56.82	41.20	39.78	-	-
PS Ratio	16.07	21.87	24.17	124.77	863.17	1059.02
PB Ratio	-59.68	-75.24	-44.24	24.25	7.60	8.78
P/TBV Ratio	-	-	-	24.70	7.64	8.84
EV/Sales Ratio	16.57	22.35	24.92	117.92	754.73	931.41
Debt / Equity Ratio	-4.67	-8.10	-4.42	1.93	0.12	0.11
Asset Turnover	0.57	0.36	0.28	0.05	0.01	0.01
Inventory Turnover	0.30	0.18	0.26	0.12	-	-
Quick Ratio	0.70	0.81	0.62	1.06	7.03	13.75
Current Ratio	1.03	1.17	0.95	1.29	8.03	14.02
Return on Equity (ROE)	-	-	-818.43%	-101.69%	-44.54%	-58.36%
Return on Assets (ROA)	-7.69%	-17.38%	-29.73%	-32.29%	-27.35%	-24.95%
Return on Capital (ROIC)	-12.99%	-27.89%	-44.83%	-39.89%	-29.42%	-26.42%
Return on Capital Employed (ROCE)	-82.20%	-102.60%	-511.40%	-150.60%	-45.90%	-35.70%
Earnings Yield	-2.24%	-4.75%	-7.47%	-9.13%	-5.71%	-5.69%
FCF Yield	-1.08%	-3.87%	-7.29%	-7.99%	-6.57%	-3.96%
Buyback Yield / Dilution	-5.56%	-2.85%	-0.38%	-2.37%	-8.21%	-8.84%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.